What is Rotator Cuff Injury Therapy Market?
The rotator cuff is the injury of muscles that form the rotator cuff is frayed or damaged. Rotator cuff injury therapy is the physical therapy is required to treat the rotator cuff. Physical therapy is only way to get back the strength and movement after injury. Rotator cuff injury therapy provides the benefits including, get back range of motion, learn exercises to strengthen shoulder muscles, improve the sit and down posture These factors driving the growth rotator cuff injury therapy market. Rising population’s sports-related activities and injuries sowing the high growth in the rotator cuff injury therapy market.
Highlights from Rotator Cuff Injury Therapy Market Study
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Unit | Value (USD Million) |
Key Companies Profiled | Medtronic (United States), The Cooper Companies Inc. (United States), Cook Group (United States), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (United States), FUJIFILM Irvine Scientific (United States), Kitazato Corporation (Japan), Hamilton Thorne Ltd. (United States), Abbott (United States) and Philips (Netherlands) |
The global rotator cuff injury therapy market is fragmented. It provides benefits such as, get back range of motion, and learn an exercise to strengthen shoulder muscles, improve the sit and down posture. So the players are focusing on the launch of highly advanced arthroscopic treatment devices. These will enhance their market presence. The companies are also planning strategic activities like partnerships, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Rotator Cuff Injury Therapy market throughout the forecasted period.
Medtronic (United States), The Cooper Companies Inc. (United States), Cook Group (United States), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (United States), FUJIFILM Irvine Scientific (United States), Kitazato Corporation (Japan), Hamilton Thorne Ltd. (United States), Abbott (United States) and Philips (Netherlands) are some of the key players profiled in the study. Rotator Cuff Injury Therapy Market Segmentation:
Scope | Sub-Segments |
---|
Application / End User | Hospital and Sport Industry |
Type | Arthroscopic Surgery, Open Surgery and Mini-open Surgery |
| |
By Treatment | Non-surgical Treatments,Surgical Treatments |
On the basis of geography, the market of Rotator Cuff Injury Therapy has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- Enhancing Demand of Surgical or Curative Treatment
- Rising Number of Shoulder Injuries Especially in the Sports Sector
Market Trend
- Growing Awareness about the Benefits Associated With an Arthroscopic Repair
- Increasing Technological Advancements in Arthroscopic Surgical Devices
Restraints
- High Cost Associated with the Arthroscopic Surgical Procedures
Opportunities
- Enhancing Opportunity Coupled with the Regenerative Biologics
- Rising Healthcare Expenditure
Challenges
- Concerns related to Failure Rate of Rotator Cuff Injury Treatment
Market Leaders & Development Strategies
On 17th June 2021, The Johnson & Johnson Medical Devices Companies announced that the DePuy Synthes Mitek sports medicine division, a leading developer of sports medicine products and soft tissues repair devices, now offers DYNACORD suture in Europe. The high-strength, self-tensioning DYNACORD suture is used for the soft tissue approximation in rotator cuff repairs. DYNACORD is designed to shorten compression lost, thereby minimizing the gap formation through axial contraction. DYNACORD suture shown in pre-clinical testing to migrate suture laxity, creep, knot slippage or the loss of compressions due to load spikes.
On 7th March 2021, Sparta Biopharma is developing osteobiologics for sports medicine and announces the availability of BioEnthesis, is the first allograft that both mineralized and demineralized layers provide the requisite properties for healing and repair of within the rotator cuff. As per the Healthcare Cost and Utilization Project, there are more than 4.5 million physician visits per year for rotator cuff pain and dysfunction.
Key Target Audience
Rotator Cuff Injury Therapy Providers, New Entrants, Regulatory Bodies, Potential Investors, Research and Development Institutes and Others